Skip to main content

Table 2 Univariate analysis of associations of normalized molecular and immune features with overall survival. P-value was calculated using log rank sum test. Hazard Ratio (HR)> 1 indicates negative correlation with OS.

From: Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis

Feature

HR (95% CI)

P value

ImmuneScore

0.69 (0.51, 0.93)

0.014

IFN-γ Index

0.54 (0.41, 0.72)

 < 0.001

Expanded Immune Gene Signature

0.59 (0.45, 0.78)

 < 0.001

T cell-inflamed Gene Signature

0.57 (0.44, 0.76)

 < 0.001

Oxidative Phosphorylation (OXPHOS) Index

1.16 (0.88, 1.51)

0.292

MCP-Counter Cell type prediction

 T cells

0.65 (0.52, 0.83)

 < 0.001

 CD8 T cells

0.78 (0.62, 0.98)

0.035

 Cytotoxic lymphocytes

0.72 (0.55, 0.94)

0.017

 NK Cells

0.71 (0.54, 0.95)

0.019

 B lineage

0.83 (0.65, 1.07)

0.150

 Monocytic lineage

0.69 (0.52, 0.92)

0.012

 Myeloid dendritic cells

0.90 (0.70, 1.14)

0.370

 Neutrophils

1.33 (0.99, 1.79)

0.057

 Endothelial cells

0.98 (0.76, 1.27)

0.884

 Fibroblasts

0.87 (0.68, 1.12)

0.281